Design and use of potent, specific enzyme inhibitors
- 31 December 1983
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 23 (1) , 45-78
- https://doi.org/10.1016/0163-7258(83)90026-8
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- A phosphorus-containing pyrimidine analog as a potent inhibitor of cytidine deaminaseBiochemical and Biophysical Research Communications, 1982
- The importance of G0 in the site of action of interferon in the cell cycleExperimental Cell Research, 1981
- Rapid inactivation of cathepsin L by Z-Phe-PheCHN2 and Z-Phe-AlaCHN2Biochemical and Biophysical Research Communications, 1981
- Specific and potent inhibition of spermidine synthase by the transition-state analog, S-adenosyl-3-thio-1,8-diaminooctaneBiochemical and Biophysical Research Communications, 1980
- Selective enhancement of 5-fluorouridine uptake and action in rat hepatomas in vivo following pretreatment with d-galactosamine and 6-azauridine or N-(phosphonacetyl)-l-aspartatePublished by Elsevier ,1980
- Changes in the X-ray solution scattering of aspartate transcarbamylase following the allosteric transitionJournal of Molecular Biology, 1979
- Initial characterization of a HTC cell variant partially resistant to the anti-proliferative effect of ornithine decarboxylase inhibitorsExperimental Cell Research, 1978
- δ-(phosphonacetyl)-L-ornithine, a potent transition state analogue inhibitor of ornithine carbamoyltransferaseBiochemical and Biophysical Research Communications, 1977
- Catalytic inhibition of γ-aminobutyric acid-α-ketoglutarate transaminase of bacterial origin by 4-aminohex-5-ynoic acid, a substrate analogBiochemical and Biophysical Research Communications, 1975
- Crystal structure of a lysozyme-tetrasaccharide lactone complexJournal of Molecular Biology, 1974